Your session is about to expire
← Back to Search
Smartphone-Based Progressive Muscle Relaxation Therapy (PMR) for Migraine
This trial is testing whether a smartphone app can help people with migraines and sleep problems. The app, RELAXaHEAD, uses progressive muscle relaxation to try and help with symptoms. The study will compare people who use the app to those who receive usual care.
- Multiple Sclerosis
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are new participants allowed to register for this study?
"As per the information posted on clinicaltrials.gov, this medical research activity is actively recruiting patients for participation. It was initially announced to the public on June 9th 2022 and underwent its last revision a month later (July 18th)."
How many participants are enrolled in this experiment?
"Affirmative, the clinical trial is still recruiting participants. First posted on June 9th 2022 and most recently updated on July 18th 2022, this experiment requires 56 subjects from a single site to be enrolled."
May I join the research endeavor?
"This clinical trial is enrolling 56 people, aged 18 to 80, with established migraine. Patients must also adhere to the following qualifications: ICHD classification of migraines & MIDAS scores >5 for 4+ headache days per month OR PTH diagnosis in accordance with ICHD criteria within 3-12 months post injury and ISI score ≥15."
Are people aged 55 and over eligible to partake in this experiment?
"As per the study's selection criteria, participants must be between the ages of 18 and 80."
What are the intended outcomes of this specific experiment?
"The primary end-point tracked over a Baseline and Month 3 period is Change in Migraine Disability Assessment Scale (MIDAS) Scores. Secondary outcomes being assessed include Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress: Depressionn Migraine Disability Assessment Scale (MIDAS) Scores. Secondary outcomes being assessed include Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional Distress: Depression Score, Minutes/Day of Progressive Muscle Relaxation Therapy (PMR) Use among RELAX Arm Participants, and Perceived Stress Scale (PSS) Scores."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends